Opioid and nonopioid analgesic agents: Some aspects of central (spinal) and peripheral actions

Pain Reviews

Volumn 4, Issue 4, 1997, Pages 205-229

  Jurna, Ilmar ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANILINE DERIVATIVE; DICLOFENAC; DIPYRONE; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOROLAC; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PARACETAMOL; PHENAZONE; PROPYPHENAZONE; PYRAZOLONE DERIVATIVE; ZOMEPIRAC;

ANALGESIC ACTIVITY; ANTINOCICEPTION; CHRONIC PAIN; DRUG MECHANISM; DRUG RESPONSE; GENE INDUCTION; HUMAN; IMMEDIATE EARLY GENE; NONHUMAN; PAIN; REVIEW;

EID: 0031464510     PISSN: 09681302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (320)

1. Schaumann, O. Analgetika und 'protektives' System. Naturwissensch 1954; 41: 96.
2. Blume, W. Über die Wirkung des Morphins auf das Rückenmark der dekapitierten Katze. Naunyn Schmiedebergs Arch Pathol Exp Parmakol 1927; 119: 24-30.
3. Wikler A. Studies on the action of morphine on the central nervous system of the cat. J Pharmacol Exp Ther 1944; 80: 176-87.
4. Irwin S, Houde RW, Bennett DR, Hendershot LC. The effect of morphine, methadone, and meperidine on some reflex responses of spinal animals to nociceptive stimulation. J Pharmacol Exp Ther 1951; 101: 132-43.
5. Cook L, Bonnycastle DD. An examination of some spinal and ganglionic actions of analgesic materials. J Pharmacol Exp Ther 1953; 109: 34-44.
6. Martin WR, Eades CG, Fraser HF, Wikler A. Use of hind limb reflexes of the chronic spinal dog for comparing analgesics. J Pharmacol Exp Ther 1964; 144: 8-11.
7. Yaksh TL. Spinal opiate analgesia: characteristics and principles of action. Pain 1981; 11: 293-346.
8. Duggan AW, North RA. Electrophysiology of opioids. Pharmacol Rev 1984; 35: 219-81.
9. Willer JC, Bussel B. Evidence for a direct spinal mechanism in morphine-induced inhibition of nociceptive reflexes in humans. Brain Res 1980; 187: 212-15.
10. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-36.
11. Yaksh TL, Rudy TA. Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther 1977; 202: 411-28.
12. Dewey WL, Snyder JW, Harris LS, Howes JF. The effect of narcotics and narcotic antagonists on the tail-flick response in spinal mice. J Pharm Pharmacol 1969; 21: 548-50.
13. Jurna I. Dämpfung repetitiver Aktivierungsvorgänge durch Morphin. In: Janzen R, Keidel WD, Herz A, Steichele C eds. Schmerz: Grundlagen - Pharmakologie - Therapie. Stuttgart: Georg Thieme, 1972: 267-69.
14. Basbaum AI, Marley NJE, O'Keefe J, Clanton CH. Reversal of morphine and stimulus-produced analgesia by subtotal spinal cord lesions. Pain 1977; 3: 43-56.
15. Hayes RL, Price DD, Bennett GJ, Wilcox GL, Mayer DJ. Differential effects of spinal cord lesions on narcotic and non-narcotic suppression of nociceptive reflexes: further evidence for the physiologic multiplicity of pain modulation. Brain Res 1978; 155: 91-101.
16. Barton C, Basbaum AI, Fields HL. Dissociation of supraspinal and spinal actions of morphine: a quantitative evaluation. Brain Res 1980; 188: 487-98.
17. Yaksh TL. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res 1979; 160: 180-85.
18. Jensen TS, Yaksh TL. Examination of spinal monoamine receptors through which brainstem opiate-sensitive systems act in the rat. Brain Res 1986; 363: 114-27.
19. Reynolds DV. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 1969; 164: 444-45.
20. Mayer DJ, Wolfe TL, Akil H, Carder B, Liebeskind JC. Analgesia from electrical stimulation in the brainstem of the rat. Science 1971; 174: 1351-54.
21. Mayer DJ, Price DD. Central nervous system mechanisms of analgesia. Pain 1976; 2: 379-404.
22. Mayer DJ, Liebeskind JC. Pain reduction by focal electrical stimulation of the brain: an anatomical and behavioural analysis. Brain Res 1974; 68: 73-93.
23. Lewis VA, Gebhart GF. Evaluation of the periaqueductal gray (PAG) as a morphine-specific locus of action and examination of morphine-induced and stimulation-produced analgesia at coincident PAG loci. Brain Res 1977; 124: 283-303.
24. Oliveras JL, Besson J-M, Guilbaud G, Liebeskind JC. Behavioral and electrophysiological evidence of pain inhibition from midbrain stimulation in the cat. Exp Brain Res 1974; 20: 32-44.
25. Dickenson AH, Oliveras JL, Besson J-M. Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat. Brain Res 1979; 170: 95-111.
26. Le Bars D, Dickenson AH, Besson J-M. Microinjection of morphine within nucleus raphe magnus and dorsal horn neurone activities related to nociception in the rat. Brain Res 1980; 189: 467-81.
27. Jacquet YF, Lajtha A. The periaqueductal gray: site of morphine analgesia and tolerance as shown by 2-way cross tolerance between systemic and intracerebral injections. Brain Res 1976; 103: 501-13.
28. Fields HL, Anderson SD. Evidence that raphe-spinal neurons mediate opiate and midbrain stimulation-produced analgesias. Pain 1978; 5: 333-49.
29. Llewelyn MB, Azami J, Roberts MHT. Brainstem mechanism of antinociception. Effects of electrical stimulation and injection of morphine into the nucleus raphe magnus. Neuropharmacology 1986; 25: 727-35.
30. Vigouret J, Teschemacher HJ, Albus K, Herz A. Differentiation between spinal and supraspinal sites of action of morphine when inhibiting the hindleg flexor reflex in rabbits. Neuropharmacology 1973; 12: 111-21.
31. Jurna I. Inhibition of the effect of repetitive stimulation of motoneurones of the cat by morphine and pethidine. Neuropharmacology 1966; 5: 117-23.
32. Jurna I, Grossmann W, Theres C. Inhibition by morphine of repetitive activation of cat spinal motoneurones. Neuropharmacology 1973; 12: 983-93.
33. Jurna I, Schäfer H. Depression of post-tetanic potentiation in the spinal cord by morphine and pethidine. Experientia 1965; 21: 226-27.
34. Jurna I. Depression of facilitatory influences on spinal motor activity by carisoprodol. J Neuropharmacol 1965; 4: 245-54.
35. Struppler A, Burgmayer B, Ochs GB, Pfeiffer HG. The effect of epidural application of opioids on spasticity of spinal origin. Life Sci 1983; 33 (suppl 1): 607-10.
36. Erickson DL, Blacklock JB, Michaelson M, Sperling KB, Lo JN. Control of spasticity by implantable continuous flow morphine pump. Neurosurgery 1985; 16: 215-17.
37. Müller H, Gerlack H, Boldt J et al. Spastik-Behandlung mit rückenmarksnaher Gabe von Morphin oder Midazolam. In vitro-Experimente, Tierversuche und klinische Untersuchungen zur Verträglichkeit und Effektivität. Anaesthesist 1986; 35: 306-16.
38. Siegfried J, Rea GL. Intrathecal application of drugs for muscle hypertonia. Scand J Rehabil Med 1988; (suppl 17): 145-48.
39. Erickson DL, Michaealson M. Control of intractable spasticity with intrathecal morphine sulfate. Neurosurgery 1989; 24: 236-38.
40. Dostrovsky JO, Pomeranz B. Morphine blockade of amino acid putative transmitters on cat spinal cord sensory interneurones. Nature 1973; 246: 222-24.
41. Zieglgänsberger W, Puil EA. Actions of glutamic acid on spinal neurons. Exp Brain Res 1973; 17: 35-49.
42. Calvillo O, Henry JL, Neuman RS. Effects of morphine and naloxone on dorsal horn neurones in the cat. Can J Physiol Pharmacol 1974; 52: 1207-11.
43. Duggan AW, Davies J, Hall JG. Effects of opiate agonists on central neurons of the cat. J Pharmacol Exp Ther 1976; 196: 107-20.
44. Zieglgänsberger W, Bayerl H. The mechanism of inhibition of neuronal activity by opiates in the spinal cord of cat. Brain Res 1976; 115: 111-28.
45. Besse D, Lombard MC, Zajac JM, Roques BP, Besson J-M. Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res 1990; 521: 15-22.
46. Stevens CW, Lacey CB, Miller KE, Elde R, Seybold VS. Biochemical characterization and regional quantification of μ, δ and κ opioid binding sites in rat spinal cord. Brain Res 1991; 550: 77-85.
47. Mendell LM. Physiological properties of unmyelinated fiber projections to the spinal cord. Exp Neurol 1966; 16: 316-31.
48. Besson J-M, Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol Rev 1987; 67: 67-186.
49. Davies SN, Lodge D. Evidence for involvement of N-methyl-D-aspartate receptors in 'wind up' of class 2 neurons in the dorsal horn of the rat. Brain Res 1987; 424: 402-406.
50. Dickenson AH, Sullivan AF. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurons following C fiber stimulation. Neuropharmacology 1987; 26: 1235-38.
51. Skilling SR, Smullin DH, Beiz AJ, Larson AA. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J Neurochem 1988; 51: 127-32.
52. Thompson SWN, Woolf CJ. Primary afferent-evoked prolonged potentials in the spinal cord and their central summation: role of the NMDA receptor. In: Bond MR, Carlton JE, Woolf CJ eds. Proceedings of the VIth World Congress on Pain (Pain research and clinical management, vol. 4); 1990 Apr 1-6; Adelaide, South Australia. Amsterdam: Elsevier, 1991: 291-98.
53. Gamse R, Holzer P, Lembeck F. Indirect evidence for presynaptic location of opiate receptors on chemosensitive primary neurones. Naunyn Schmiedebergs Arch Pharmacol 1979; 308: 281-85.
54. Fields HL, Emson PC, Leigh BK, Gilbert RFT, Iversen LL. Multiple opiate receptor sites on primary afferent fibres. Nature 1980; 284: 351-53.
55. Yaksh TL, Jessel TM, Gamse R, Mudge AW, Leeman SE. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature 1980; 286: 155-57.
56. Zieglgänsberger W. Opioid actions on mammalian spinal neurons. Int Rev Neurobiol 1984; 25: 243-75.
57. Hori Y, Endo K, Takahashi T. Presynaptic inhibitory action of enkephalin on excitatory transmission in superficial dorsal horn of rat spinal cord. J Physiol (Lond) 1992; 450: 673-85.
58. Woodworth RS, Sherrington CS. A pseudaffective reflex and its spinal path. J Physiol (Lond) 1904; 31: 234-43.
59. Zetler G. Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8). Neuropharmacology 1980; 19: 415-22.
60. Jurna I, Zettler G. Antinociceptive effect of centrally administered cerulein and cholecystokinin octapeptide (CCK-8). Eur J Pharmacol 1981; 73: 323-31.
61. Doi T, Jurna I. Analgesic effect of intrathecal morphine demonstrated in ascending nociceptive activity in the rat spinal cord and ineffectiveness of cerulein and cholecystokinin octapeptide. Brain Res 1982; 234: 399-407.
62. Farris PL, Komisaruk BR, Watkins LR, Mayer DJ. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 1983; 219: 310-12.
63. Watkins LR, Kinscheck IB, Mayer DJ. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide, a cholecystokinine antagonist. Science 1984; 224: 395-96.
64. Yaksh TL, Abay EO, Go VL. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord. Brain Res 1982; 242: 279-90.
65. Stanfa L, Dickenson AH, Xu X-J, Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol Sci 1994; 15: 65-66.
66. Jurna I. Aminophylline differentiates between the depressant effects of morphine on the spinal nociceptive reflex and on spinal ascending activity evoked from afferent C fibres. Eur J Pharmacol 1981; 71: 393-400.
67. Jurna I. Cyclic nucleotides and aminophylline produce different effects on nociceptive motor and sensory responses in the rat spinal cord. Naunyn Schmiedebergs Arch Pharmacol 1984; 327: 23-30.
68. Stone TW, Perkins MN. Is adenosine the mediator of opiate action on neuronal firing rate? Nature 1979; 281: 227-28.
69. Perkins MN, Stone TW. Blockade of striatal neurone responses to morphine by aminophylline: evidence for adenosine mediation of opiate action. Br J Pharmacol 1980; 69: 131-38.
70. Ginzler AR, Musacchio JM. Interactions of morphine, adenosine, adenosine triphosphate and phosphodiesterase inhibitors on the field-stimulated guinea-pig ileum. J Pharmacol Exp Ther 1975; 194: 575-82.
71. Sawynok J, Jhamandas KH. Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenosine nucleotides and morphine: antagonism by theophylline. J Pharmacol Exp Ther 1976; 197: 379-90.
72. Phillis JW, Jiang ZG, Chelack BJ, Wu PH. The effect of morphine on purine and acetylcholine release from rat cerebral cortex: evidence for a purinergic component in morphine's action. Pharmacol Biochem Behav 1980; 13: 421-27.
73. Stone W. The effects of morphine and methionine-enkephalin on the release of purines from cerebral cortex slices of rats and mice. Br J Pharmacol 1981; 74: 171-76.
74. Jhamandas K, Sawynok J, Sutak M. Antagonism of morphine action on brain acetylcholine release by methylxanthines and calcium. Eur J Pharmacol 1978; 49: 309-12.
75. Perkins MN, Stone TW. Aminophylline and theophylline derivatives of neuronal depression by adenosine: a microiontophoretic study. Arch Pharmacodyn Ther 1980; 246: 205-14.
76. Duggan AW, Griersmith BT. Methylxanthines, adenosine 3′,5′-cyclic monophosphate and the spinal transmission of nociceptive information. Br J Pharmacol 1979; 67: 51-57.
77. Holmgren M, Hedner J, Mellstrand T, Nordberg G, Hedner T. Characterization of the antinociceptive effects of some adenosine analogues in the rat. Naunyn Schmiedebergs Arch Pharmacol 1986; 334: 290-93.
78. Belville JW, Escarraga LA, Wallenstein SL, Wang KC, Howland WS, Houde RW. Antagonism by caffeine of the respiratory effects of codeine and morphine. J Pharmacol Exp Ther 1962; 136: 38-42.
79. Stirt JA. Aminophylline may act as a morphine antagonist. Anaesthesia 1983; 38: 275-78.
80. Siegmund E, Cadmus R, Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc Soc Exp Biol (New York) 1957; 95: 729-31.
81. Subcommittee on Taxonomy of the International Association for the Study of Pain. Classification of chronic pain. Description of chronic pain syndromes and definitions of pain terms. Part II: Pain terms: a current list with definitions and notes on usages. Pain 1986; (suppl 3): S215-21.
82. Lim RKS. Pain. Annu Rev Physiol 1970; 32: 269-88.
83. Lembeck F, Juan H. Influence of changed calcium and potassium concentration on the algesic effect of bradykinin and acetylcholine. Naunyn Schmiedebergs Arch Pharmacol 1977; 299: 289-94.
84. Cervero F. Dorsal horn neurons and their sensory inputs. In: Yaksh TL ed. Spinal afferent processing. New York: Plenum Press, 1986: 197-216.
85. Willis WD. Ascending somatosensory systems. In: Yaksh TL ed. Spinal afferent processing. New York: Plenum Press, 1986: 243-74.
86. Haley JE, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990; 518: 218-26.
87. Besson JM, Catchlove RFH, Feltz P, Le Bars D. Further evidence for postsynaptic inhibitions on lamina V dorsal horn interneurone. Brain Res 1974; 66: 531-36.
88. Hökfelt T, Kellerth JO, Nilsson G, Pernow B. Substance P: localization in the central nervous system and in some primary sensory neurons. Science 1975; 190: 889-90.
89. La Motte CC. Organization of dorsal horn neurotransmitter systems. In: Yaksh TL ed. Spinal afferent processing. New York: Plenum Press, 1986: 97-116.
90. De Biasi S, Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci USA 1988; 85: 7820-24.
91. McNeill DL, Westlund KN, Coggeshall RE. Peptide immunoreactivity of unmyelinated primary afferent axons in rat lumbar dorsal roots. J Histochem Cytochem 1989; 37: 1047-52.
92. Tuchscherer MM, Seybold VS. A quantitative study of the coexistence of peptides in varicosities within the superficial laminae of the dorsal horn of the rat spinal cord. J Neurosci 1989; 9: 195-205.
93. Kuraishi Y, Hirota N, Sugimoto M, Satoh M, Takagi H. Effects of morphine on noxious stimuli-induced release of substance P from rabbit dorsal horn in vivo. Life Sci 1983; 33: 693-96.
94. Mudge AW, Leeman SE, Fischbach GD. Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc Natl Acad Sci USA 1979; 76: 526-30.
95. Lembeck F, Donnerer J, Colpaert FC. Increase of substance P in primary afferent nerves during chronic pain. Neuropeptides 1981; 1: 175-80.
96. Schoenen J, Van Hees J, Gybels J, De Castro Costa M, Venderhagen JJ. Histochemical changes of substance P, FRAP, serotonin and succinic dehydrogenase in the spinal cord of rats with adjuvant arthritis. Life Sci 1985; 36: 1247-54.
97. B receptor system. Br J Pharmacol 1994; 113: 1561-66.
98. Schaible HG, Jarrott B, Hope PJ, Duggan AW. Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes. Brain Res 1990; 529: 214-23.
99. Pearson J, Brandeis I, Cuello AC. Depletion of substance P containing axons in substantia gelatinosa of patients with diminished pain sensitivity. Nature 1982; 295: 61-63.
100. Xu J, Pollock CH, Kajander KC. Chronic gut suture reduces calcitonin-gene-related peptide and substance P levels in the spinal cord following chronic constriction injury in the rat. Pain 1996; 64: 503-509.
101. Yaksh TL. The central pharmacology of primary afferents with emphasis on the disposition and role of primary afferent substance P. In: Yaksh TL ed. Spinal afferent processing. New York: Plenum Press, 1986: 165-95.
102. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976; 197: 517-32.
103. Lord JAH, Waterfield AA, Hughes J, Kosterlitz HW. Endogenous opioid peptides: multiple agonists and receptors. Nature 1977; 267: 495-99.
104. Wüster M, Schulz R, Herz A. Specificity of opioids towards the μ-, δ- and κ-opiate receptors. Neurosci Lett 1978; 15: 193-98.
105. Gouarderes C, Cros J, Quirion R. Autoradiographic localisation of μ, δ and κ receptor binding sites in rat and guinea pig spinal cord. Neuropeptides 1985; 6: 331-42.
106. Morris BJ, Herz A. Distinct distribution of opioid receptor types in rat lumbar spinal cord. Naunyn Schmiedebergs Arch Pharmacol 1987; 336: 240-43.
107. Zajac JM, Lombard MC, Peschanski M, Besson JM, Roques BP. Autoradiographic study of μ and δ opioid binding sites and neutral endopeptidase-24-II in rat after dorsal root rhizotomy. Brain Res 1989; 477: 400-403.
108. Vaught JL. What is the relative contribution of mu, delta and kappa opioid receptors to antinociception and is there cross tolerance? In: Basbaum AI, Besson J-M eds. Towards a new pharmacotherapy of pain. Chichester: Wiley, 1991: 121-36.
109. Danzebrink RM, Green SA, Gebhart GF. Spinal mu and delta, but not kappa, opioid receptor agonists attenuate responses to noxious colorectal distension in the rat. Pain 1995; 63: 39-47.
110. Seybold VS. Neurotransmitter sites in the spinal cord. In: Yaksh TL ed. Spinal afferent processing. New York: Plenum Press, 1986: 117-39.
111. Ruda MA. The pattern and place of nociceptive modulation in the dorsal horn. A discussion of the anatomically characterized neural circuitry of enkephalin, serotonin, and substance P. In: Yaksh TL ed. Spinal afferent processing. New York: Plenum Press, 1986: 141-64.
112. Ruda MA, Bennett GJ, Dubner R. Neurochemistry and neural circuitry in the dorsal horn. In: Emson PC, Rossor MN, Fouyama M eds. Progress in brain research, vol. 66. Amsterdam: Elsevier, 1986: 219-68.
113. Duggan AW, Weihe E. Central transmission of impulses in nociceptors: events in the superficial dorsal horn. In: Basbaum AI, Besson J-M eds. Towards a new pharmacotherapy of pain. Chichester: Wiley, 1991: 35-67.
114. Sar M, Stumpf WE, Miller RJ, Chang KJ. Cuatrecasas P. Immunohistochemical localization of enkephalin in rat brain and spinal cord. J Comp Neurol 1978; 182: 17-38.
115. Seybold V, Elde R. Immunohistochemical studies of peptidergic neurons in the dorsal horn of the spinal cord. J Histochem Cytochem 1980; 28: 367-70.
116. Gibson SJ, Polak JM, Bloom SR, Wall PD. The distribution of nine peptides in rat spinal cord with special emphasis on the substantia gelatinosa and on the area around the central canal (lamina X). J Comp Neurol 1981; 201: 65-79.
117. Glazer EJ, Basbaum AI. Immunohistochemical localization of leucine-enkephalin in the spinal cord of the rat: enkephalin containing marginal neurones and pain modulation. J Comp Neurol 1981; 196: 377-89.
118. Bennett GJ, Ruda MA, Gobel S, Dubner R. Enkephalin immunoreactive stalked cells and lamina IIb islet cells in cat substantia gelatinosa. Brain Res 1982; 240: 162-66.
119. 2-, and μ-opioid receptor agonists on excitatory transmission in lamina II neurons of adult spinal cord. J Neurosci 1994; 14: 4965-71.
120. Yaksh TL. The effects of intrathecally administered opioid and adrenergic agents on spinal function. In: Yaksh TL ed. Spinal afferent processing. New York: Plenum Press, 1986: 505-39.
121. North RA. Drug receptors and the inhibition of nerve cells. Br J Pharmacol 1989; 98: 13-28.
122. Atweh SA, Kuhar MJ. Autoradiographic localisation of opiate receptors in rat brain. I: Spinal cord and lower medulla. Brain Res 1977; 124: 53-67.
123. Mack KJ, Killian A, Weyhenmeyer JA. Comparison of mu, delta, and kappa opiate binding sites in rat brain and spinal cord. Life Sci 1984; 34: 281-85.
124. Jurna I, Baldauf J, Fleischer W. Depression by morphine-6-glucuronide of nociceptive activity in rat thalamus neurons: comparison with morphine. Brain Res 1996; 722: 132-38.
125. Åkermann B, Arweström E, Post C. Local anesthetics potentiate spinal morphine antinociception. Anesth Analg 1988; 67: 943-48.
126. Fraser HM, Chapman V, Dickenson AH. Spinal local anaesthetic action on afferent evoked responses and wind-up of nociceptive neurones in the rat spinal cord: combination with morphine produces marked potentiation of antinociception. Pain 1992; 49: 33-41.
127. Nagy I, Woolf C. Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics. Pain 1996; 64: 59-70.
128. Tabatai M, Booth AM. Mechanism of action of local anesthetics on synaptic transmission in the rat. Anesth Analg 1990; 71: 149-57.
129. Kuno M, Matsumura S. Site and mechanism of action of lidocaine upon the isolated spinal cord of the frog. Brain Res 1982; 249: 87-93.
130. Woolf CJ, Wiesenfeld-Hallin Z. The systemic administration of local anaesthetics produced a selective depression of C-afferent fibre evoked activity in the spinal cord. Pain 1985; 23: 361-74.
131. Kayser V, Guilbaud G. Dose-dependent analgesic and hyperalgesic effects of systemic naloxone in arthritic rats. Brain Res 1981; 226: 344-48.
132. Kayser V, Guilbaud G. The analgesic effects of morphine, but not those of the enkephalinase inhibitor thiorphan are enhanced in arthritic rats. Brain Res 1983; 267: 131-38.
133. Millan MJ, Millan MH, Czlonowski A et al. A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritis. J Neurosci 1986; 6: 899-906.
134. Neil A, Kayser V, Gacel G, Besson J-M, Guilbaud G. Opioid receptor types and antinociceptive activity in chronic inflammation: both κ- and μ-opiate agonist effects are enhanced in arthritic rats. Eur J Pharmacol 1986; 130: 203-208.
135. Lombard M-C, Besson J-M. Electrophysiological evidence for a tonic activity in the spinal cord intrinsic opioid systems in a chronic pain model. Brain Res 1989; 477: 48-56.
136. Carstens E, Tulloch I, Zieglgänsberger W, Zimmermann M. Presynaptic excitability changes by morphine in single cutaneous afferent C- and A-fibers. Pflügers Arch 1979; 379: 143-47.
137. Sastry BR. Potentiation of presynaptic inhibition of nociceptive pathways as a mechanism for analgesia. Can J Physiol Pharmacol 1980; 58: 97-100.
138. Jessell TM, Iversen LL. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature 1977; 268: 549-51.
139. Jurna I, Grossmann W. The effect of morphine on mammalian nerve fibres. Eur J Pharmacol 1977; 44: 339-48.
140. Maekawa K, Minami M, Masuda T, Satoh M. Expression of μ- and κ-, but not δ-, opioid receptor mRNAs is enhanced in the spinal dorsal horn of arthritic rats. Pain 1995; 64: 365-71.
141. Cesselin F, Montastruc JL, Gros C, Bourgoin S, Hamon M. Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats. Brain Res 1980; 191: 289-93.
142. Delay-Goyet P, Kayser V, Zajac J-M, Guilbaud G, Besson J-M, Roques BP. Lack of significant changes in mu, delta opioid binding sites and neutral endopeptidase EC 3.4.24.11 in the brain and spinal cord of arthritic rats. Neuropharmacology 1989; 28: 1341-48.
143. Millan MJ, Czlonowski A, Morris B et al. Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat. Pain 1988; 35: 299-312.
144. Fields HL. Can opiates relieve neuropathic pain? [Editorial] Pain 1988; 35: 365.
145. Portenoy RK, Foley KM, Inturrisi CE. The nature of responsiveness and its implication for neuropathic pain: new hypothesis derived from studies of opioid infusions. Pain 1990; 43: 273-86.
146. Bowsher D. Neurogenic pain syndromes and their management. Br Mrd Bull 1991; 47: 644-66.
147. Bowsher D. Pain syndromes and their treatment. Curr Opin Neurol Neurosurg 1993; 6: 257-63.
148. Arnér S, Meyerson BA. Lack of effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988: 33: 11-23.
149. Kupers RC, Konings H, Adriaensen H, Gybels JM. Morphine differentially affects sensory and affective pain ratings in neurogenic and idiopathic forms of pain. Pain 1991; 46: 5-12.
150. Davar G, Maciewicz RJ. Deafferentation pain syndromes. Neurol Clin 1989; 7: 289-304.
151. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993; 52: 259-85.
152. Lewin GR, Mendell LM. Nerve growth factor and nociception. Trends Neurosci 1993; 16: 353-59.
153. Henry JL. Participation of substance P in spinal physiological responses to peripheral aversive stimulation. Regul Pept 1993; 46: 138-43.
154. 2 receptor activation to high threshold afferent fibre evoked ventral root responses in the rat spinal cord in vitro. Brain Res 1993; 625: 100-108.
155. Malcangio M, Bowery NG. Calcitonin gene-related peptide content, basal outflow and electrically-evoked release from monoarthritic rat spinal cord in vitro. Pain 1996; 66: 351-58.
156. Lipton SA, Rosenberg PA. Excitatory amino acids as final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-22.
157. Woolf CJ. A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization. Drugs 1994; 47 (suppl 5): 1-9.
158. Dickenson AH, Sullivan AF. Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurons in the dorsal horn. Pain 1986; 24: 211-22.
159. Chapman V, Dickenson AH. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res 1992; 573: 321-23.
160. Schaible H-G, Grubb BD, Neugebauer V, Oppmann M. The effects of NMDA antagonists on neuronal activity in cat spinal cord evoked by acute inflammation in the knee joint. Eur J Neurosci 1991; 3: 981-91.
161. Murray CW, Cowan A, Larsson AA. Neurokinin and NMDA antagonists (but not kainic acid antagonists) are antinociceptive in the mouse formalin model. Pain 1991; 44: 179-85.
162. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 1992; 12: 3665-70.
163. Coderre TJ, Melzack R. The role of NMDA receptor-operated calcium channels in persistent nociception after formalin-induced tissue injury. J Neurosci 1992; 12: 3671-75.
164. Coderre TJ, Vaccarino AL, Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 1990; 535: 155-58.
165. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161-74.
166. Wheeler-Aceto H, Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacology 1991; 104: 35-44.
167. Murray CW, Porreca F, Cowan A. Methodological refinements to the mouse paw formalin test: an animal model of tonic pain. J Pharmacol Methods 1988; 20: 175-86.
168. Tjolsen A, Berge O-G, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992; 51: 5-17.
169. Tanganelli S, Antonelli T, Morari M, Bianchi C, Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci Lett 1991; 122: 270-72.
170. Mao J, Price DD, Mayer DJ. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 1994; 14: 2301-12.
171. Marek P, Ben-Eliyahu S, Gold M, Liebeskind JC. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res 1991; 547: 77-81.
172. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in the brain. Nature 1988; 336: 385-88.
173. Garthwaite J, Garthwaite G, Palmer RMJ, Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur J Pharmacol 1989; 172: 413-16.
174. Knowles RG, Palacios M, Palmer RJM, Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 1989; 86: 5159-62.
175. Dun NJ, Dun SL, Forsterman U, Tseng LF. Nitric oxide synthase immunoreactivity in rat spinal cord. Neurosci Lett 1992; 147: 217-20.
176. Valtschanoff JG, Weiberg RG, Rustioni A. NADPH diaphorase in the spinal cord of rats. J Comp Neurol 1992; 321: 209-22.
177. Haley JE, Dickenson AH, Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology 1992; 31: 251-58.
178. G-nitroarginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol 1991; 102: 198-202.
179. G-nitroarginine-p-nitroanilide is antinociceptive in the mouse. NeuroReport 1993; 4: 307-10.
180. Malmberg AB, Yaksh TL. Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain 1993; 54: 291-300.
181. Kitto KF, Haley JE, Wilcox GW. Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse. Neurosci Lett 1992; 148: 1-5.
182. O'Dell TJ, Hawkins RD, Kandel ER, Arancio O. Test of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 1991; 88: 11285-89.
183. Sorkin LS. NMDA evokes an L-NAME sensitive spinal release of glutamate and citrulline. NeuroReport 1993; 4: 479-82.
184. Wilcox GL. Spinal mediators of nociceptive neurotransmission and hyperalgesia. Relationships among synaptic plasticity, analgesic tolerance, and blood flow. J Am Pain Soc 1993; 2: 265-75.
185. Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993; 52: 127-36.
186. Carlsson K-H, Monzel W, Jurna I. Depression by morphine and the non-opioid analgesic agents, metamizol (dipyrone), lysine acetylsalicylate and paracetamol, of activity in rat thalamus neurones evoked by electrical stimulation of nociceptive afferents. Pain 1988; 32: 313-26.
187. Zimmermann M, Herdegen T. Control of gene transcription by jun and fos proteins in the nervous system. Beneficial or harmful molecular mechanisms of neuronal response to noxious stimulation? J Am Pain Soc 1994; 3: 33-48.
188. Kehl LJ, Gogas KR, Lichtblau L et al. The NMDA antagonist MK801 reduces noxious stimulus-evoked fos expression in the spinal cord dorsal horn. In: Bond MR, Charlton JE, Woolf CJ eds. Proceedings of the VIth World Congress on Pain (Pain research and clinical management, vol. 4); 1990 Apr 1-6; Adelaide, South Australia. Amsterdam: Elsevier, 1991: 307-11.
189. Bereiter DA, Bereiter DF, Hathaway CB. The NMDA receptor antagonist MK-801 reduces fos-like immunoreactivity in central trigeminal neurons and blocks selectively endocrine and autonomic responses to corneal stimulation in the rat. Pain 1996; 64: 179-89.
190. Presley RW, Menétrey D, Levine JD, Basbaum AI. Systemic morphine suppresses noxious stimulus-evoked fos protein-like immunoreactivity in the rat spinal cord. J Neurosci 1990; 10: 323-35.
191. Tölle TR, Castro LJ, Coimbra A, Zieglgänsberger W. Opiates modify induction of c-fos protooncogene in the spinal cord of the rat following noxious stimulation. Neurosci Lett 1990; 111: 46-51.
192. Hammond DL, Presley RW, Gogas KR, Levine JD, Basbaum AI. Morphine or U-50488 suppress fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarius evoked by a noxious visceral stimulus in the rat. J Comp Neurol 1992; 315: 244-53.
193. Gogas KR, Cho HJ, Botchkinal GI, Levine JD, Basbaum AI. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine. Pain 1996; 65: 9-15.
194. Stein C, Hassan AHS, Przewlocki R, Gramsch C, Peter K, Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990; 87: 5935-39.
195. Joris JL, Dubner R, Hargreaves KM. Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation. Anesth Analg 1987; 66: 1277-81.
196. Stein C, Millan MJ, Shippenberg TS, Herz A. Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat. Neurosci Lett 1988; 84: 225-28.
197. Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 1989; 248: 1269-75.
198. Ferreira SH, Nakamura M. Prostaglandin hyperalgesia. Prostaglandins 1979; 18: 179-208.
199. Stein C, Gramsch C, Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and β-endorphin. J Neurosci 1990; 10: 1292-98.
200. Russell NJW, Schaible H-G, Schmidt RF. Opiates inhibit the discharges of fine afferent units from inflamed knee joint of the cat. Neurosci Lett 1987; 76: 107-12.
201. Yaksh TL. Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res 1988; 458: 319-24.
202. Khoury GF, Stein C, Garland DE. Intra-articular morphine for pain after knee arthroscopy. Lancet 1990; 326: 874.
203. Stein C, Comisel K, Haimerl E et al. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N Engl J Med 1991; 325: 1123-26.
204. Hoffmann L. Salicylsäure gegen Neuralgien. Berlin Klin Wochenschr 1876; 13: 494-95.
205. Hanzlik PJ. Actions and uses of the salicylates and cinchophen in medicine. In: Edsall DL, Chesney AM eds. Medicine: analytical reviews of general medicine, neurology and pediatrics, vol. V. Baltimore, MD: Williams and Wilkins, 1926: 197-373.
206. Woodbury DM. Analgesics and antipyretics. In: Goodman LS, Gilman A eds. The pharmacological basis of therapeutics, third edition. New York: Pergamon Press, 1965: 314.
207. Flower RJ, Moncada S, Vane JR. Analgesic-antipyretics and anti-inflammatory agents: drugs employed in the treatment of gout. In: Gilman AG, Goodman LS, Gilman A eds. The pharmacological basis of therapeutics, sixth edition. New York: Pergamon Press, 1980: 683.
208. Spector WG. Substances which affect capillary permeability. Pharmacol Rev 1958; 10: 475-512.
209. Lewis GP. Active polypeptides derived from plasma proteins. Physiol Rev 1960; 40: 647-79.
210. Rocha e Silva M, Rosenthal SR. Release of pharmacologically active substances from rat skin in vivo following thermal injury. J Pharmacol Exp Ther 1961; 132: 110-23.
211. Armstrong D, Dry RML, Keele CA, Markham JW. Observations on chemical excitants of cutaneous pain in man. J Physiol (Lond) 1953; 120: 325-36.
212. Armstrong D, Jepson JB, Keele CA, Stewart JW. Pain producing substances in the human inflammatory exudates and plasma. J Physiol (Lond) 1957; 135: 350-69.
213. Fjällbrant N, Iggo A. The effect of histamine, 5-hydroxytryptamine and acetylcholine on cutaneous afferent fibres. J Physiol (Lond) 1961; 156: 578-90.
214. Guzman F, Braun C, Lim RKS, Potter GD, Rodgers DW. Narcotic and non-narcotic analgesics which block visceral pain evoked by intra-arterial injection of bradykinin and other algesic agents. Arch Int Pharmacodyn Ther 1964; 149: 571-88.
215. Moncada S, Ferreira SH, Vane JR. Pain and inflammatory mediators. Handbook Exp Pharmacol 1979; 30: 293-331.
216. Handwerker HO. Influences of algogenic substances and prostaglandins on the discharges of myelinated cutaneous nerve fibres identified as nociceptors. In: Bonica JJ, Albe-Fessard D eds. Advances in pain research and therapy, vol. 1. New York: Raven Press, 1976: 41-45.
217. 1 on rat cutaneous afferent nerve activity. Br J Pharmacol 1977; 59: 343-47.
218. Andoh R, Sakurada S, Satoh S, Takahashi N, Kisara K. Potentiating effects of prostaglandin E2 on bradykinin and capsaicin responses in medial thalamic nociceptive neurons. Jpn J Pharmacol 1982; 32: 81-89.
219. Yanagisawa M, Otsuka M, Garcia-Arraras J. E-type prostaglandins depolarize primary afferent neurons of the neonatal rat. Neurosci Lett 1986; 68: 351-55.
220. Mense S. Reduction of the bradykinin-induced activation of feline group III and IV muscle receptors by acetylsalicylic acid. J Physiol (Lond) 1982; 326: 269-83.
221. Guilbaud G, Iggo A. The effect of lysine acetylsalicylate on joint capsule mechanoreceptors in rats with polyarthritis. Exp Brain Res 1985; 61: 164-68.
222. Attal N, Kayser V, Eschalier A, Benoist JM, Guilbaud G. Behavioural and electrophysiological evidence for an analgesic effect of a non-steroidal anti-inflammatory agent, sodium diclofenac. Pain 1988; 35: 341-48.
223. Heppelmann B, Pfeffer A, Schaible HG, Schmidt RF. Effects of acetylsalicylic acid and indomethacin on single groups III and IV sensory units from acutely inflamed joints. Pain 1986; 26: 337-51.
224. Steen KH, Reeh PW, Kreysel HW. Topical acetylsalicylic acid and indomethacin suppress pain from experimental tissue acidosis in human skin. Pain 1995; 62: 329-47.
225. Flower RJ, Gryglewski R, Herbaczynska-Cedro K, Vane JR. Effects of antiinflammalory drugs on prostaglandin biosynthesis. Nature (New Biol) 1973; 238: 104-106.
226. Ferreira SH, Vane JR. New aspects of the mode of action of nonsteroid antiinflammatory drugs. Annu Rev Pharmacol 1974; 14: 57-73.
227. Higgs GA, Palmer RMJ, Eakins KE, Moncada S. Arachidonic acid metabolism as a source of inflammatory mediators and its inhibitions as a mechanism of anti-inflammatory drugs. Mol Aspects Med 1981; 4: 275-301.
228. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol). Nature (New Biol) 1972; 240: 410-11.
229. Dembinska-Kiec A, Zmuda A, Krupinska J. Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations. Adv Prostaglandin Thromboxane Res 1976; 1: 99-103.
230. Von Bruchausen FV, Baumann J. Inhibitory actions of desacetylation products of phenacetin on prostaglandin synthesis in neuronal and glial cell lines and rat renal medulla. Life Sci 1982; 30: 1783-91.
231. Brune K, Alpermann H. Non-acidic pyrazoles: inhibition of prostaglandin production, carrageenan oedema and yeast fever. Agents Actions 1983; 13: 360-63.
232. Engelhardt G. Zur Pharmakologie der 'schwach wirksamen Analgetika'. In: Forth W ed. Zur Problematik der schwachwirksamen Analgetika. TW Taschenbuch Medizin, Band 7. Stuttgart: G Braun Druckerei und Verlage, 1985: 100-108.
233. Trautmann M, Peskar BM, Pritze S, Luck W, Hoppe U. Effects of metamizol and its metabolites on eicosanoid release from anaphylactic guinea pig lung and rat gastric mucosa. In: Zos U, Naor Z, Danon A eds. Leukotrienes and prostanoids in health and disease (New trends in lipid mediators research, vol. 3). 1989: 210-15.
234. Brune K, Beck WS, Geisslinger G, Menzel-Soglowek S, Peskar BM, Peskar BA. Aspirin-like drugs may block pain independently of prostaglandin synthesis inhibition. Experientia 1991; 47: 257-61.
235. Bannwarth B, Desmotes-Mainard F, Schaeverbeke T, Labat L, Dehaus J. Central analgesic effects of aspirin-like drugs. Fundam Clin Pharmacol 1995; 9: 1-7.
236. Pircio AW, Fedele CT, Bierwagen ME. A new method for the evaluation of analgesic activity using adjuvant-induced arthritis in the rat. Eur J Pharmacol 1975; 31: 207-15.
237. Dubas TC, Parker JM. A central component in the analgesic action of sodium salicylate. Arch Int Pharmacodyn Ther 1971; 194: 117-22.
238. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol) 1971; 231: 232-35.
239. Tolman EL, Partridge R. Multiple sites of interaction between prostaglandins and non-steroidal anti-inflammatory agents. Prostaglandins 1975; 9: 349-59.
240. Schmidt J. Der Einfluß nichtnarkotischer Analgetika auf durch Zahnpulpareizung ausgelöste Hirnpotentiale. Acta Biol Germ 1972; 28: 371-78.
241. Haegerstam G, Edwall L. Sodium acetylsalicylate and the role of prostaglandins in the mechanisms of intradental pain. Acta Odont Scand 1977; 35: 63-67.
242. Jurna I, Brune K. Central effect of the non-steroid anti-inflammatory agents, indomethacin, ibuprofen, and diclofenac, determined in C fibre-evoked activity in single neurones of the rat thalamus. Pain 1990; 41: 71-80.
243. Ferreira SH, Lorenzetti BB, Corrêa FMA. Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 1978; 53: 39-48.
244. Okuyama S, Aihara H. The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: possible central analgesic action of acidic nonsteroidal anti-inflammatory drugs. Jpn J Pharmacol 1984; 35: 95-103.
245. Hunskaar S, Fasmer OB, Hole K. Acetylsalicylic acid, paracetamol and morphine inhibit behavioural responses to intrathecally administered substance P or capsaicin. Life Sci 1985; 37: 1835-41.
246. Shyu KW, Lin MT. Hypothalamic monoaminergic mechanisms of aspirin-induced analgesia in monkeys. J Neural Transm 1985; 62: 285-93.
247. Groppetti A, Braga PC, Biella G, Parenti M, Rusconi L, Mantegazza P. Effect of aspirin on serotonin and metenkephalin in brain: correlation with the antinociceptive activity of the drug. Neuropharmacology 1988; 27: 499-505.
248. Paalzow L. Studies on the relationship between the analgesic activity of salicylic acid and the brain catecholamines in mice. Acta Pharmacol Toxicol 1973; 32: 11-21.
249. Biella G, Groppetti A. Correlation between the antinociceptive effect of aspirin and central transmitters. Progr Pharmacol Clin Pharmacol 1993; 10: 1-9.
250. Barker JL, Levitan H. Salicylate: effect on membrane permeability of molluscan neurone. Science 1971; 172: 1245-47.
251. Levitan H, Barker JL. Effect of non-narcotic analgesics on membrane permeability of molluscan neurones. Nature (New Biol) 1972; 239: 55-57.
252. Levitan H, Barker JL. Membrane permeability: cation selectivity reversibly altered by salicylate. Science 1972; 178: 63-64.
253. Riccioppo Neto F, Narahashi T. Ionic mechanism of salicylate block of nerve conduction. J Pharmacol Exp Ther 1976; 199: 454-63.
254. Riccioppo-Neto F. Further studies on the actions of salicylates on nerve membranes. Eur J Pharmacol 1980; 68: 155-62.
255. Chen ACN, Chapman CR. Aspirin analgesia evaluated by event-related potentials in man: possible central action in brain. Exp Brain Res 1980; 39: 359-64.
256. Bromm B, Scharein E. Alterations in the human EEG induced by acetylsalicylic acid and related drugs. Progr Pharmacol Clin Pharmacol 1993; 10: 23-40.
257. Willer JC, Harrewyn JM. Effet inhibiteur central du kétoprofène intraveneux sur le réflexe nociceptif de flexion chez l'homme. Presse Med 1987; 16: 63-67.
258. Willer JC. A supraspinal mechanism is involved in the central analgesic effect of ketoprofen, a non-steroidal anti-inflammatory drug, in man. Progr Pharmacol Clin Pharmacol 1993; 10: 23-40.
259. Jensen TS, Rasmussen P. Phantom pain and related phenomena after amputation. In: Wall PD, Melzack R eds. Textbook of pain. Edinburgh: Churchill Livingstone, 1989: 508-21.
260. Beric A, Dimitrijevic MR, Lindblom U. Central dysesthesia syndrome in spinal cord injury patients. Pain 1988; 34: 109-17.
261. Watson CPN, Evans RJ, Watt VR, Birkett N. Post-herpetic neuralgia: 208 cases. Pain 1988; 35: 289-97.
262. Watson CPN, Watt VR, Chipman M, Birkett N, Evans RJ. The prognosis with post-herpetic neuralgia. Pain 1991; 46: 195-99.
263. 2α and related enzymes in post mortem human brain. J Neurochem 1984; 43: 71-82.
264. Romero SD, Chyatte D, Byer DE, Romero JC, Yaksh TL. Measurement of prostaglandins in the cerebrospinal fluid in cat, dog, and man. J Neurochem 1984; 43: 1642-49.
265. Leslie JB, Watkins WD. Eicosanoids in the central nervous system. J Neurosurg 1985; 63: 659-68.
266. Marriott DR, Wilkins GP, Coote PR, Wood JN. Eicosanoid synthesis by spinal cord astrocytes is evoked by substance P: possible implications for nociception and pain. Adv Prostaglandin Thromboxane Leukot Res 1990; 21: 739-41.
267. Vesin M-F, Pralong E, Droz B. PGE2 synthesis in chick spinal cord and high affinity PGE2 receptors on motoneurons. Adv Prostaglandin Thromboxane Leukot Res 1990; 21: 735-38.
268. 2 in rat brain, spinal cord and pituitary: basal level and regional distribution. Life Sci 1982; 31: 2093-103.
269. Wolfe LS, Rostworowski K, Pappius HM. The endogenous biosynthesis of prostaglandins by brain tissue in vitro. Can J Biochem 1976; 54: 629-40.
270. Wolfe LS. Prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J Neurochem 1982; 38: 1-14.
271. 2 binding sites in rat brain using quantitative autoradiography. Brain Res 1992; 581: 292-98.
272. Ramwell PW, Shaw JE, Jessup R. Spontaneous and evoked release of prostaglandins from frog spinal cord. Am J Physiol 1966; 211: 998-1004.
273. 2 is noradrenergic terminal dependent. Neurosci Lett 1990; 115: 253-58.
274. Yaksh TL. Central and peripheral mechanisms for the antialgesic action of acetylsalicylic acid. In: Barnett HJM, Hirsh J, Mustard JF eds. Acetylsalicylic acid: new aspects for an old drug. New York: Raven Press, 1982: 137-51.
275. Marriott DR, Wilkins GP, Wood JN. Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism. J Neurochem 1991; 56: 259-65.
276. Vasko MR, Zirkelbach SL, Waite KJ. Prostaglandins stimulate the release of substance P from rat spinal cord slices. Progr Pharmacol Clin Pharmacol 1993; 10: 51-89.
277. Hingtgen CM, Vasko MR. Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons. Brain Res 1994; 655: 51-60.
278. Vasko MR. Prostaglandin-induced neuropeptide release from spinal cord. Progr Brain Res 1995; 104: 367-80.
279. Hingtgen CM, Waite KJ, Vasko MR. Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade. J Neurosci 1995; 15: 5411-19.
280. 2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J Neurosci 1994; 14: 4987-97.
281. Ferreira SH. Prostaglandins: peripheral and central analgesia. In: Bonica JJ, Lindblom U, Iggo A eds. Advances in pain research and therapy, vol. 5. New York: Raven Press, 1983: 627-34.
282. 2α to conscious mice. Brain Res 1990; 510: 26-32.
283. 2α. Brain Res 1986; 373: 81-84.
284. 2α to conscious mice. Pain 1992; 50: 223-29.
285. 2 to conscious mice. Pain 1994; 57: 217-23.
286. 1 produces a long lasting allodynic state. Pain 1995; 63: 303-11.
287. Jurna I. Acetylsalicylic acid and related compounds depress nociceptive activity in the thalamus by a central action: indication for the involvement of prostaglandins. Progr Pharmacol Clin Pharmacol 1993; 10: 51-68.
288. Kanterman RYT, Brenneman CC, Ma DE, Fitzgerald S, Axelrod J. Alpha 1-adrenergic receptor mediates arachidonic acid release in spinal cord neurons independent of inositol phospholipid turnover. J Neurochem 1990; 54: 1225-32.
289. Kanterman RY, Axelrod J, Felder CC. Alpha 1-adrenergic receptor mediates the release of arachidonic acid in spinal cord neurons independent of phosphatidylinositol-specific phospholipase. Adv Second Messenger Phosphoprot Res 1990; 24: 158-63.
290. Taiwo YO, Levine JD. Prostaglandins inhibit endogenous pain control mechanisms by blocking transmission at spinal noradrenergic synapses. J Neurosci 1988; 8: 1346-49.
291. Malmberg AB, Yaksh TL. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257: 1276-79.
292. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263: 136-46.
293. Rampin O, Harrewyn JM, Suaudeau C, Thiebaut JB, Albe-Fessard D. Possible central analgesic action of ketoprofen on two animal models of pain. Algologia 1989; 1: 35-41.
294. Jurna I, Spohrer B, Bock R. Intrathecal injection of acetylsalicylic acid, salicylic acid and indomethacin depresses C fibre-evoked activity in the rat thalamus and spinal cord. Pain 1992; 49: 249-56.
295. Jurna I, Baldauf J. Formalininduzierte Hyperalgesie bei Ratten und ihre Beseitigung durch intrathekale Injektion von Prostaglandinsynthesehemmstoffen und Morphin. Der Schmerz 1993; 7 (suppl 1): V 1.7.
296. Devoghel JC. Small intrathecal doses of lysine acetylsalicylate relieve intractable pain in man. J Int Med Res 1983; 11: 90-91.
297. Devoghel JC. Intrathecal injection of lysine acetylsalicylate in man with intractable cancer pain. Progr Pharmacol Clin Pharmacol 1993; 10: 111-18.
298. Pellerin M, Hardy F, Abergel A et al. Douleur chronique rebelle des cancéreux: intérêt de l'injection intrarachidienne d'acétylsalicylate de lysine: soixante observations. Presse Med 1987; 16: 1465-68.
299. Svensson BA, Karlsten R, Kristensen JD, Sottile A, Bennett A, Gordh T. Intrathecal injection of lysine acetylsalicylic acid in the rat: a neurotoxicological study. Acta Anaesthesiol Scand 1993; 37: 799-805.
300. Gründling P, He X, Schaible HG, Schmidt RF. Effects of metamizol on the spontaneous discharges of fine afferent fibres from inflamed knee joints of the cat [Abstract]. Eur J Physiol 1988; 411 (suppl 1): R178.
301. Neugebaurer V, Schaible HG, He X, Lücke T, Gründling P, Schmidt RF. Electrophysiological evidence for a spinal antinociceptive action of dipyrone. Agents Actions 1994; 41: 62-70.
302. Carlsson K-H, Helmreich J, Jurna I. Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizol (dipyrone). Pain 1986; 27: 373-90.
303. Tortorici V, Vanegas H. Putative role of medullary off- and on-cells in the antinociception produced by dipyrone (metamizol) administered systemically or microinjected into the PAG. Pain 1994; 57: 197-205.
304. Vanegas H, Barbaro NM, Fields HL. Tail-flick related activity in medullospinal neurons. Brain Res 1984; 321: 135-41.
305. Carlsson K-H, Helmreich J, Jurna I. Comparison of central antinociceptive and analgesic effects of the pyrazolone derivatives, metamizol (dipyrone) and aminophenazone ('Pyramiden'). Schmerz Pain Douleur 1986; 7: 93-100.
306. Jurna I. Die Wirkung von 1-phenyl-2,3-dimethyl-4-dimethyl-aminopyrazolon (Pyramidon) und 1-phenyl-2,3-dimethyl-4-isopropylaminopyrazolon (Isopyrin) auf spinale Reflexe. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1963; 245: 305-20.
307. Jurna I. Depression of the dorsal root potential of the cat spinal cord by amidopyrine. Int J Neuropharmacol 1966; 5: 361-65.
308. Clissold SP. Aspirin related derivatives of salicylic acid. Drugs 1986; (suppl 4): 8-26.
309. McCormack K, Brune K. Dissociation between the antinociceptive and antiinflammatory effects of the nonsteroidal antiinflammatory drugs. A survey of their analgesic efficacy. Drugs 1991; 41: 533-47.
310. McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994; 59: 9-43.
311. Brune K, Menzel-Soglowek S, Zeilhofer HU. New evidence for an additional (central) site of action of antipyretic analgesics. Progr Pharmacol Clin Pharmacol 1993; 10: 41-50.
312. Geisslinger G, Ferreira SH, Menzel S, Schlott D, Brune K. Antinociceptive action of R(-)-flurbiprofen - a non-cyclooxygenase inhibiting 2-arylpropionic acid in rats. Life Sci 1994; 54: 173-77.
313. Malmberg AB, Yaksh TL. Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formallin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 1993; 79: 270-81.
314. Malmberg AB, Yaksh TL. Spinal actions of non-steroidal anti-inflammatory drugs: evidence for a central role of prostanoids in nociceptive processing. Progr Pharmacol Clin Pharmacol 1993; 10: 91-106.
315. Fitzpatrick FA, Wynalda MA. In vivo suppression of prostaglandin biosynthesis by non-steroidal anti-inflammatory agents. Prostaglandins 1976; 12: 1037-51.
316. 2 levels in mouse brain. Eur J Pharmacol 1990; 179: 25-34.
317. Meade EA, Smith WL, De Witt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993; 268: 6610-14.
318. Mitchell JA, Akasareenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroid anti-inflammatory drugs as inhibitors of constitutive and inducible cyclo-oxygenase. Proc Natl Acad Sci USA 1994; 90: 11693-97.
319. Jage J, Jurna I. Opioidanalgetika. In: Zenz M, Jurna I eds. Lehrbuch der Schmerztherapie. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1993; 137-53.
320. Ramwell PW, Shaw JE. Spontaneous and evoked release of prostaglandins from cerebral cortex of anesthetized cats. Am J Physiol 1966; 211: 125-35.